Group 1 - Bayer's drug Elinzanetant (brand name Lynkuet) has been approved by the UK Medicines and Healthcare products Regulatory Agency for the treatment of moderate to severe vasomotor symptoms associated with menopause [1] - The agency indicated that the drug may also improve sleep disturbances accompanying menopause [1]